NASDAQ:ELAN - Elanco Animal Health Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$30.84 -0.92 (-2.90 %)
(As of 12/18/2018 11:01 AM ET)
Previous Close$31.76
Today's Range$30.84 - $33.03
52-Week Range$30.10 - $37.61
Volume4,831 shs
Average Volume1.47 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
There is no company description available for Elanco Animal Health Inc.

Receive ELAN News and Ratings via Email

Sign-up to receive the latest news and ratings for ELAN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry --
Sub-IndustryN/A
Sector--
Current SymbolNASDAQ:ELAN
Previous Symbol
CUSIPN/A
WebN/A
PhoneN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares365,630,000
Market Cap$0.00
OptionableOptionable

Elanco Animal Health (NASDAQ:ELAN) Frequently Asked Questions

What is Elanco Animal Health's stock symbol?

Elanco Animal Health trades on the NASDAQ under the ticker symbol "ELAN."

How were Elanco Animal Health's earnings last quarter?

Elanco Animal Health (NASDAQ:ELAN) released its quarterly earnings data on Tuesday, November, 6th. The company reported $0.29 EPS for the quarter, topping analysts' consensus estimates of $0.25 by $0.04. The company had revenue of $761.10 million for the quarter, compared to analysts' expectations of $766.26 million. The firm's quarterly revenue was up 9.2% on a year-over-year basis. During the same period in the prior year, the firm posted $0.14 EPS. View Elanco Animal Health's Earnings History.

When is Elanco Animal Health's next earnings date?

Elanco Animal Health is scheduled to release their next quarterly earnings announcement on Tuesday, February 5th 2019. View Earnings Estimates for Elanco Animal Health.

How can I listen to Elanco Animal Health's earnings call?

Elanco Animal Health will be holding an earnings conference call on Wednesday, February 13th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

What guidance has Elanco Animal Health issued on next quarter's earnings?

Elanco Animal Health issued an update on its FY19 earnings guidance on Tuesday, December, 18th. The company provided earnings per share (EPS) guidance of $1.02-1.12 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.07. The company issued revenue guidance of $3.10-3.16 billion, compared to the consensus revenue estimate of $3.10 billion.Elanco Animal Health also updated its FY18 guidance to $1.14-1.16 EPS.

What price target have analysts set for ELAN?

10 brokers have issued 12 month price objectives for Elanco Animal Health's stock. Their forecasts range from $30.00 to $38.00. On average, they anticipate Elanco Animal Health's share price to reach $34.8750 in the next twelve months. This suggests a possible upside of 9.5% from the stock's current price. View Analyst Price Targets for Elanco Animal Health.

What is the consensus analysts' recommendation for Elanco Animal Health?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Elanco Animal Health in the last year. There are currently 6 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Elanco Animal Health.

Has Elanco Animal Health been receiving favorable news coverage?

Headlines about ELAN stock have been trending negative this week, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Elanco Animal Health earned a media sentiment score of -2.4 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 5.0 out of 10, meaning that recent press coverage is somewhat likely to have an impact on the company's share price in the next several days.

Who are some of Elanco Animal Health's key competitors?

When did Elanco Animal Health IPO?

(ELAN) raised $1.4 billion in an IPO on Thursday, September 20th 2018. The company issued 62,900,000 shares at $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Barclays, BNP PARIBAS, BofA Merrill Lynch, Citigroup, Credit Suisse, Deutsche Bank Securities, Evercore ISI, Cowen, Academy Securities, Drexel Hamilton, Mischler Financial Group, Ramirez and The Williams Capital Group were co-managers.

When does Elanco Animal Health's lock-up period expire?

Elanco Animal Health's lock-up period expires on Tuesday, March 19th. Elanco Animal Health had issued 62,900,000 shares in its initial public offering on September 20th. The total size of the offering was $1,509,600,000 based on an initial share price of $24.00. After the expiration of Elanco Animal Health's lock-up period, company insiders and major shareholders will be able to sell their shares of the company.

Who are Elanco Animal Health's major shareholders?

Elanco Animal Health's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Morgan Stanley (2.46%), Vanguard Group Inc. (1.38%), Vanguard Group Inc (1.38%), Primecap Management Co. CA (1.05%), FMR LLC (0.92%) and Capital World Investors (0.67%). Company insiders that own Elanco Animal Health stock include Jeffrey N Simmons, Lawrence Erik Kurzius and Ramiro Martin Cabral. View Institutional Ownership Trends for Elanco Animal Health.

Which institutional investors are buying Elanco Animal Health stock?

ELAN stock was acquired by a variety of institutional investors in the last quarter, including Morgan Stanley, Vanguard Group Inc, Vanguard Group Inc., Primecap Management Co. CA, FMR LLC, Capital World Investors, Wells Fargo & Company MN and Dodge & Cox. Company insiders that have bought Elanco Animal Health stock in the last two years include Jeffrey N Simmons, Lawrence Erik Kurzius and Ramiro Martin Cabral. View Insider Buying and Selling for Elanco Animal Health.

How do I buy shares of Elanco Animal Health?

Shares of ELAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Elanco Animal Health's stock price today?

One share of ELAN stock can currently be purchased for approximately $31.84.


MarketBeat Community Rating for Elanco Animal Health (NASDAQ ELAN)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  30 (Vote Outperform)
Underperform Votes:  36 (Vote Underperform)
Total Votes:  66
MarketBeat's community ratings are surveys of what our community members think about Elanco Animal Health and other stocks. Vote "Outperform" if you believe ELAN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ELAN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel